We are live on
!
Find out more
DCM
DAFNA Capital Management Portfolio holdings
AUM
$440M
1-Year Est. Return
109.12%
This Fund
S&P 500
This Quarter
Est. Return
+56.7%
1 Year Est. Return
+109.12%
3 Year Est. Return
+239.59%
5 Year Est. Return
+227.89%
10 Year Est. Return
+3,611.91%
AUM
$347M
AUM Growth
+$107M
(+45%)
Cap. Flow
+$3.61M
Cap. Flow
% of AUM
1.04%
Top 10 Holdings %
Top 10 Hldgs %
48.52%
Holding
96
New
16
Increased
11
Reduced
34
Closed
8
Top Buys
| 1 |
IMMU
Immunomedics Inc
IMMU
|
+$7.34M |
| 2 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
+$6.6M |
| 3 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
+$6.16M |
| 4 |
Syndax Pharmaceuticals
SNDX
|
+$5.48M |
| 5 |
Liquidia Corp
LQDA
|
+$4.17M |
Top Sells
| 1 |
AtriCure
ATRC
|
+$4.64M |
| 2 |
DexCom
DXCM
|
+$4.37M |
| 3 |
Corbus Pharmaceuticals
CRBP
|
+$4.31M |
| 4 |
Compugen
CGEN
|
+$3.47M |
| 5 |
Ascendis Pharma A/S
ASND
|
+$2.68M |
Sector Composition
| 1 | Healthcare | 88.26% |
| 2 | Financials | 0.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Stereotaxis
STXS
$160M
| $61M | 17.61% |
13,680,554
| – | – |
|
|
BPMC
2
DELISTED
Blueprint Medicines
BPMC
| $17.8M | 5.13% |
228,089
| – | – |
|
3
Fate Therapeutics
FATE
$350M
| $16.8M | 4.86% |
490,861
+20,861
| +4% | +$622K |
|
|
ARNA
4
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $15.4M | 4.45% |
245,142
+65,500
| +36% | +$3.6M |
|
|
DRNA
5
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $11.5M | 3.33% |
454,236
+306,522
| +208% | +$6.6M |
|
6
Akebia Therapeutics
AKBA
$368M
| $10.4M | 2.99% |
762,666
-90,872
| -11% | -$940K |
|
7
Neurocrine Biosciences
NBIX
$17.2B
| $8.93M | 2.58% |
73,208
-7,000
| -9% | -$774K |
|
|
IMMU
8
DELISTED
Immunomedics Inc
IMMU
| $8.89M | 2.57% |
+250,905
| New | +$7.34M |
|
|
LKFT
9
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.94B
| $8.76M | 2.53% |
44,375
-2,000
| -4% | -$414K |
|
|
10
DexCom
DXCM
$28.4B
| $8.57M | 2.47% |
84,552
-48,800
| -37% | -$4.37M |
|
11
ProQR Therapeutics
PRQR
$244M
| $7.52M | 2.17% |
1,237,400
| – | – |
|
12
iShares Biotechnology ETF
IBB
$9.23B
| $7.5M | 2.17% |
54,900
-18,000
| -25% | -$2.29M |
|
13
Arcturus Therapeutics
ARCT
$182M
| $6.96M | 2.01% |
149,017
+96,431
| +183% | +$3.32M |
|
|
SAGE
14
DELISTED
Sage Therapeutics
SAGE
| $6.87M | 1.98% |
165,306
| – | – |
|
|
AGTC
15
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $6.43M | 1.86% |
1,160,878
| – | – |
|
|
BHVN
16
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $6.4M | 1.85% |
87,600
-3,000
| -3% | -$160K |
|
|
TVRD
17
Tvardi Therapeutics
TVRD
$28.5M
| $6.34M | 1.83% |
10,306
| – | – |
|
|
MRSN
18
DELISTED
Mersana Therapeutics
MRSN
| $6.32M | 1.82% |
10,807
-5,258
| -33% | -$1.8M |
|
|
19
AtriCure
ATRC
$1.75B
| $5.99M | 1.73% |
133,229
-106,500
| -44% | -$4.64M |
|
|
20
Syndax Pharmaceuticals
SNDX
$2.08B
| $5.33M | 1.54% |
+360,000
| New | +$5.48M |
|
|
21
Compugen
CGEN
$224M
| $5.15M | 1.49% |
343,046
-256,954
| -43% | -$3.47M |
|
|
CNST
22
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $5.14M | 1.48% |
+170,942
| New | +$6.16M |
|
|
LMNX
23
DELISTED
Luminex Corp
LMNX
| $5.01M | 1.45% |
154,091
-50,000
| -24% | -$1.58M |
|
24
Kura Oncology
KURA
$1B
| $4.8M | 1.38% |
294,260
-13,281
| -4% | -$192K |
|
|
CSII
25
DELISTED
Cardiovascular Systems, Inc.
CSII
| $4.77M | 1.38% |
151,200
+100,000
| +195% | +$3.74M |
|
Similar funds
FGWP
STCG
SCP
CAAM
AWM
HCM
CPW
DWML